<DOC>
	<DOCNO>NCT02895542</DOCNO>
	<brief_summary>This study find patient take anticancer medication challenge relate take cancer medication .</brief_summary>
	<brief_title>Preparatory Work Assess Adherence Oral Chemotherapy</brief_title>
	<detailed_description>120 patient Chronic Myeloid Leukemia ( CML ) currently prescribe oral anti-cancer agent 6 CCDR NCORP sit complete brief interviewer administer survey ass medication adherence related factor .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Patient diagnose Chronic Myeloid Leukemia ( CML ) receive care CML participate CCDR NCORP practice , Patient prescribe one follow oral anticancer agent CML â‰¥30 day ( Imatinib , Nilotinib , Dasatinib , Bosutinib , Ponatinib ) . Prior use medication allow , long stable regimen least 30 day prior enrollment . Patient 18 year age old Patient speak English require interpreter medical visit Patient cognitively impair , determine refer provider</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>